HIV News and Research

RSS

Boehringer Ingelheim’s interim data from Phase II HCV clinical collaboration with Presidio Pharmaceuticals accepted for presentation at AASLD

Boehringer Ingelheim today announced that interim data from its Phase II hepatitis C (HCV) clinical collaboration with Presidio Pharmaceuticals have been accepted for presentation as a late breaker poster at the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place 1-5 November in Washington, D.C. (1) The poster presentation will be on Monday 4 November.

8 Oct 2013

Scientists to highlight Bio-Rad's Droplet Digital PCR applications at CHI Digital PCR Conference

Since its introduction in 2011, Bio-Rad Laboratory's Droplet Digital PCR (ddPCR-) technology has demonstrated the potential to be a transformative technology, particularly in clinical applications.

8 Oct 2013

In South Africa, rapid progress in reducing under-five mortality

Over the past decade, South Africa has made a dramatic reversal in child survival-mainly because of improvements in HIV/AIDS care, reports a study in AIDS, official journal of the International AIDS Society. AIDS is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

8 Oct 2013

LSUHSC receives $2.76M grant to study how HIV affect oral bacterial communities

Dr. Paul Fidel, the Carl Baldridge Professor and Associate Dean for Research at LSU Health Sciences Center New Orleans' School of Dentistry, is the lead principal investigator of a $2.76 million grant from the National Institute of Dental and Craniofacial Research over five years to study how HIV and antiretroviral therapy may change communities of bacteria in the mouth and what effects those changes may have on oral infections in HIV disease.

8 Oct 2013

Babies born to moms who smoked when pregnant have increased risk of nicotine addiction in adulthood

Adult women whose mothers had increased levels of stress hormones while they were pregnant are at greater risk of becoming addicted to nicotine, according to a new study led by a Miriam Hospital researcher.

8 Oct 2013

New injection device delivers optimum treatment dose to hepatitis C patients

A new injection device, ViraferonPeg Clearclick, has launched in the UK today for hepatitis C patients to accurately titrate and self-administer their weekly dose of ViraferonPeg (peginterferon alfa-2b).

5 Oct 2013

Swallowing pills containing fecal bacteria stops recurrent bouts of C. diff infection

Swallowing pills containing a concentrate of fecal bacteria successfully stops recurrent bouts of debilitating Clostridium difficile (C. diff) infection by rebalancing the bacteria in the gut, suggests a study being presented at the IDWeek 2013- meeting today.

5 Oct 2013

Doctors prescribe antibiotics for sore throats and acute bronchitis, say researchers

A vast majority of people who see their doctors for sore throats or acute bronchitis receive antibiotics, yet only a small percentage should, according to analyses of two major national surveys being presented at IDWeek 2013-. Those illnesses usually are caused by viruses, and antibiotics - which only treat bacterial infections - do not help.

5 Oct 2013

Intervention of ID physician can reduce medication errors in hospitalized HIV patients

When patients with HIV are hospitalized for other conditions, such as a heart problem, surgery or complications of diabetes, mistakes are often made involving their complicated anti-retroviral therapy (ART) regimens.

5 Oct 2013

Research: Vaccine against norovirus reduces symptoms of illness by 52%

An investigational vaccine appears generally well tolerated and effective against the most common strain of norovirus, reducing the main symptoms of the gastrointestinal (GI) infection, vomiting and/or diarrhea, by 52 percent, suggests research being presented at IDWeek 2013.

5 Oct 2013

Scientists identify chemical agents that block flu virus's ability to replicate itself in cell culture

A new way to attack flu viruses is taking shape in laboratories at Rutgers University, where scientists have identified chemical agents that block the virus's ability to replicate itself in cell culture.

4 Oct 2013

FDA report reveals personal, professional devastation caused by cognitive dysfunctions of ME/CFS

PANDORA Org and other patient organizations say a recent report from the U.S. Food and Drug Administration (FDA) shows the agency must take further action to open up opportunities for ME/CFS drug development.

4 Oct 2013

McMaster vaccine offers new hopes for global fight against TB

A tuberculosis vaccine developed at McMaster University offers new hopes for the global fight against tuberculosis.

3 Oct 2013

Cambridge Consultants helps MSF’s efforts to widen access to HIV viral load tests

Cambridge Consultants is working with Médecins Sans Frontières (MSF) to help support moves to expand access to vital diagnostic tests, which paves the way for better treatment of HIV in some of the world’s least-developed countries.

3 Oct 2013

MTN-017 study launched to test reduced glycerin formulation of tenofovir gel

IRMA applauds the launch of the world's first-ever Phase II rectal microbicide trial. The Microbicide Trial Network's study, called MTN-017, will test a reduced glycerin formulation of tenofovir gel applied rectally.

3 Oct 2013

Researchers launch phase II clinical trial of rectal microbicide to prevent HIV infections

Taking an important step toward the development of a product to prevent HIV infections associated with unprotected anal sex, researchers today announced the launch of a global Phase II clinical trial of a potential rectal microbicide.

3 Oct 2013

UCLA study shows how cocaine makes immune cells susceptible to HIV

In many ways, the spread of HIV has been fueled by substance abuse. Shared needles and drug users' high-risk sexual behaviors are just some of the ways that narcotics such as cocaine have played a key role in the AIDS epidemic in much of the world.

3 Oct 2013

State highlights: NYC's plan to get bids for worker coverage meets roadblock; Iowa waits for Medicaid expansion waiver, readies enrollment

New York City's plan to solicit bids for health insurance for hundreds of thousands of workers has been put on hold. A Manhattan judge on Monday granted a preliminary injunction preventing the City from issuing the bids. A group of unions sued the city Aug. 10, shortly after Mayor Michael Bloomberg said the city was planning to seek bids within days. Bloomberg said the request for proposals will look to save up to $400 million a year (10/1)

2 Oct 2013

Mutant protein blocks HIV infection and transmission, scientists find

A mutant of an immune cell protein called ADAP (adhesion and degranulation-promoting adaptor protein) is able to block infection by HIV-1 (human immunodeficiency virus 1), new University of Cambridge research reveals. The researchers, who were funded by the Wellcome Trust, believe that their discovery will lead to new ways of combatting HIV.

2 Oct 2013

Data from Boehringer Ingelheim's HCV clinical program accepted for presentation at The Liver Meeting

New data from Boehringer Ingelheim's hepatitis C virus clinical development program have been accepted for presentation at the 64th Annual Meeting of the American Association for the Study of Liver Diseases, also known as The Liver Meeting®, taking place November 1-5 in Washington, D.C.

1 Oct 2013

HIV News and Research

Boehringer Ingelheim’s interim data from Phase II HCV clinical collaboration with Presidio Pharmaceuticals accepted for presentation at AASLD

Scientists to highlight Bio-Rad's Droplet Digital PCR applications at CHI Digital PCR Conference

In South Africa, rapid progress in reducing under-five mortality

LSUHSC receives $2.76M grant to study how HIV affect oral bacterial communities

Babies born to moms who smoked when pregnant have increased risk of nicotine addiction in adulthood

New injection device delivers optimum treatment dose to hepatitis C patients

Swallowing pills containing fecal bacteria stops recurrent bouts of C. diff infection

Doctors prescribe antibiotics for sore throats and acute bronchitis, say researchers

Intervention of ID physician can reduce medication errors in hospitalized HIV patients

Research: Vaccine against norovirus reduces symptoms of illness by 52%

Scientists identify chemical agents that block flu virus's ability to replicate itself in cell culture

FDA report reveals personal, professional devastation caused by cognitive dysfunctions of ME/CFS

McMaster vaccine offers new hopes for global fight against TB

Cambridge Consultants helps MSF’s efforts to widen access to HIV viral load tests

MTN-017 study launched to test reduced glycerin formulation of tenofovir gel

Researchers launch phase II clinical trial of rectal microbicide to prevent HIV infections

UCLA study shows how cocaine makes immune cells susceptible to HIV

State highlights: NYC's plan to get bids for worker coverage meets roadblock; Iowa waits for Medicaid expansion waiver, readies enrollment

Mutant protein blocks HIV infection and transmission, scientists find

Data from Boehringer Ingelheim's HCV clinical program accepted for presentation at The Liver Meeting

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News